Verification of oxytetracycline-resistant American foulbrood pathogen Paenibacillus larvae in the United States
Verification of oxytetracycline-resistant American foulbrood pathogen Paenibacillus larvae in the United States
复制标题
DOI:
10.1006/jipa.1999.4888
复制
发表时间:
2000-01-01
影响因子:
3.4
通讯作者:
Doi, RH
中科院分区:
文献类型:
--
作者:
Miyagi, T;Peng, CYS;Doi, RH
American foulbrood disease (AFB) of honeybees is the most common and virulent brood disease, causing severe damage to the beekeeping industry worldwide by decimating the infected bee colonies. AFB is caused by the microaerophilic, Gram-positive, spore-forming bacterium Paenibacillus larvae (formerly Bacillus Larvae). The disease has been under control for four decades by use of a single antibiotic-oxytetracycline hydrochloride (Terramycin) (Shimanuki et al., 1992). Recent reports (Alippi, 1996) indicated that the resurgence of AFB in Argentina was probably due to drug-resistant P. larvae. In recent years, although many beekeepers in United States have experienced the ineffectiveness of using oxytetracycline HCl (OTC) to control AFB-infected colonies, the results of a national survey did not find OTC-resistant P. larvae (Shimanuki and Knox, 1994). We verify here for the first time the existence of an OTC-resistant strain of P. larvae from AFB-infected brood. The brood comb was collected in 1998 from a Minnesota bee colony having a history of failing to respond to Terramycin treatment for AFB. Methods and procedures used in the present experiment to isolate P. larvae spores from dead brood remains and subsequent isolation and characterization of the strain grown from a single-cell colony and pathogenicity tests were carried out as described previously by Williams et al. (1998). The Bauer-Kirby disk diffusion method (Bauer et al,, 1966), following the general guidelines of NCCLS (1997), was performed to determine the zone of inhibition of the presently isolated strain of P. larvae (strain UCD-P-MN-98) by OTC, The UCD-P-MN-98 strain was compared to the bacterial culture grown from a mixed spore isolate harvested from the same Minnesota comb and to strain NRRL B-3650 (obtained from Dr. D. P. Stahly, University of Iowa, Iowa City, IA). Zone of inhibition to tylosin tartrate (Sigma Chemical Co., St. Louis, MO) was also conducted for the currently isolated strain. The minimal inhibition concentration (MIC) of OTC to UCD-PMN-98 was determined by the broth dilution susceptibility test. The present results are summarized in Table 1 and compared to previously published data. The data clearly show that the UCD-P-MN-98 strain is resistant to OTC as compared to susceptible strain NRRL B-3650, OTC-resistant strains from Argentina (Alippi, 1996), the earlier two strains isolated from California (Leighton, 1981), and the 1994 USDA study. No difference was observed in the susceptibility to tylosin in the currently tested strains. The present results confirm what the beekeepers have suspected, i.e., the presence of OTC-resistant AFB pathogen in the beehives. In wake of the current find, it is urgent that antibiotics having a pharmacological mechanism different from that of the tetracyclines, e.g., penicillins and macrolides (Okayama et al., 1994), flavomycin and virginiamycin (Stahly and Ryan, 1995), tylosin (Peng et al., 1996), and other new antibiotics, be investigated for future control of AFB to protect honeybee colonies. A detailed study on the characterization of UCD-P-MN-98 will be reported elsewhere.